Wednesday, July 8, 2026

pharma · Multiple Myeloma · Renal Cell Cancer · CRVS

Corvus Pharmaceuticals

Corvus Pharmaceuticals trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.

Burlingame, USA HQ
2014 Founded
48 Employees
Public company Type
CRVS · NYSE Ticker
Company details
Status
Public
HQ
Burlingame, USA
Founded
2014
Employees
48
Programs
9
Drugs
4
Patents
14
Intelligence · Clinical Trials

Corvus Pharmaceuticals clinical trials

Registry index of 10 ClinicalTrials.gov studies linked to Corvus Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.

Corvus Pharmaceuticals trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Corvus Pharmaceuticals.

  1. CPI-006 — Phase 1

    Clinical update
  2. CPI-006 2 mg/kg + SOC — Phase 3

    Clinical update
  3. Soquelitinib — Phase 3

    Clinical update
  4. CPI-818 — Phase 1

    Clinical update
  5. CPI-444 Capsules — Phase 1

    Clinical update
  6. Soquelitinib — Phase 2

    Clinical update
  7. CPI-006 — Phase 1

    Clinical update
  8. Ciforadenant — Phase 1

    Clinical update

Trial registry

10 studies